Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
admin A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster…
Read MorePfizer
Pfizer stock climbs on Q3 top and bottom line beat, raised outlook
Pfizer Inc.’s PFE, -1.86% stock rose 3.4% before market open on Tuesday, lifted by the…
Read MorePfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose
Pfizer Inc. PFE, +3.06% said Thursday that it plans to sell the COVID-19 shot it…
Read MorePfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose
Pfizer Inc. PFE, +4.67% said Thursday that it plans to sell the COVID-19 shot it…
Read MorePfizer and BioNTech report positive data in trial of omicron-targeting bivalent booster in individuals aged 18 and older
Pfizer Inc. PFE, +0.26% and German partner BioNTech SE BNTX, +5.53% said Thursday early data…
Read MorePfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for…
Read MorePfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for…
Read MoreVaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over
Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said…
Read MoreReport finds Americans with long COVID losing billions in wages, as Moderna sues Pfizer and BioNTech over mRNA patents
Some 16 million Americans of working age have long-term COVID and as many as 4…
Read MoreModerna sues Pfizer and BioNTech for patent infringement relating to the mRNA platform used to develop COVID vaccines
Moderna Inc. MRNA, -1.49% said Friday it is suing Pfizer Inc. PFE, -1.06% and German…
Read More